Since during chronic inflammation adhesion molecule-dependent infiltration of immune cells to the liver is an important step in the progression from NAFLD to NASH, the aim of this study was to analyse the expression of CD62L in human samples from patients with acute and chronic liver injury. Here, SELL is linked to metabolic dysfunction-associated steatotic liver disease.